OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-NLRC4 antibodies

Anti-NLRC4 Antibody

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA317772
  • IPAF / NLRC4 Rabbit Polyclonal (C-Terminus) Antibody
50ug 345 3-7 Days
Add to Shopping Cart
IHC(1)

OriGene Data

ImmunogenSynthetic peptide from human NLRC4 / IPAF.
Clone Name IsotypeIgG
Species ReactivityHuman Concentration1 mg/ml
Guaranteed Application *IHC Suggested DilutionsICC, IHC-P (5 µg/ml), WB (0.5 - 2 µg/ml)
BufferPBS, 0.02% sodium azide.
Purification Immunoaffinity Chromatography
Note synthetic peptide corresponding to amino acids near the C-terminus of human Ipaf

Reference Data

Target NameHomo sapiens NLR family, CARD domain containing 4 (NLRC4), transcript variant 1
Alternative NameAIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; IPAF
Database LinkNP_067032
Entrez Gene 58484 Human
Function
Related Pathway NOD-like receptor signaling pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

IHC Image
Anti-NLRC4 antibody IHC staining of human brain, cortex. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title